{"product_id":"sysmex-business-model-canvas","title":"Sysmex Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSysmex Business Model Canvas: Blueprint for Scalable, Investable Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock Sysmex’s strategic playbook with our full Business Model Canvas—detailing customer segments, value propositions, revenue streams, and partner ecosystems to show exactly how the company scales and sustains competitive advantage; ideal for investors, consultants, and founders seeking actionable, ready-to-use insights in Word and Excel formats.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSysmex partners with major diagnostic firms—covering 60+ countries via regional distributors—to boost reach for hematology and urinalysis systems; co-marketing and exclusive regional rights raised international revenue to ¥232.6 billion in FY2024 (ended Mar 2025), ~38% of sales from overseas distribution channels.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Academic Collaborations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSysmex partners with top universities and institutions—supporting over 120 joint studies and 45 clinical trials worldwide in 2024—to co-discover biomarkers and validate diagnostics, driving a pipeline that contributed ~15% of FY2024 R\u0026amp;D-linked revenue and improved assay sensitivity by up to 22% in select hematology tests.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Component and Raw Material Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSysmex relies on specialized suppliers for electronic parts and chemical raw materials for reagents, with long-term contracts covering ~60–70% of procurement spend to ensure continuity and cut supply-chain volatility; joint quality-control programs and supplier audits help meet medical-device regs (e.g., ISO 13485) and reduced defect rates to \u0026lt;0.5% in 2024, lowering recall risk and protecting revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and IT Service Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSysmex partners with software developers and IT infrastructure providers to embed AI and cloud computing into laboratory information systems, enabling advanced analytics and remote monitoring; in 2024 Sysmex’s digital solutions segment grew ~12% YoY, contributing an estimated ¥48 billion in revenue.\u003c\/p\u003e\n\u003cp\u003eThese tech alliances cut turnaround times, support predictive diagnostics, and help labs lower operating costs by up to 15% in pilot programs, improving patient management and workflow efficiency.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 digital revenue ~¥48bn\u003c\/li\u003e\n\u003cli\u003eSegment growth ~12% YoY\u003c\/li\u003e\n\u003cli\u003ePilot Opex reduction ~15%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Health and Government Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSysmex partners with national health ministries and WHO-linked programs to deploy diagnostics for screenings and surveillance, supporting \u0026gt;30 country programs and driving roughly ¥28.4 billion (2024) institutional revenue from public-sector contracts.\u003c\/p\u003e\n\u003cp\u003eThese deployments bolster local lab capacity in emerging economies, align Sysmex with WHO priorities like AMR and cancer screening, and expand long-term institutional sales pipelines by ~12% annually.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSupports 30+ national programs\u003c\/li\u003e\n\u003cli\u003e¥28.4 billion public revenue (2024)\u003c\/li\u003e\n\u003cli\u003e~12% annual pipeline growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSysmex partnerships fuel ¥309bn FY2024 revenue, cut defects \u0026lt;0.5% and Opex ~15%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSysmex’s key partners—distributors in 60+ countries, 120+ academic collaborators, suppliers with 60–70% long-term contracts, IT vendors, and public-health programs—drove FY2024 revenue contributions: ¥232.6bn international, ¥48bn digital, ¥28.4bn public; partnerships cut defect rates \u0026lt;0.5% and pilot Opex by ~15%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eFY2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003eInternational revenue\u003c\/td\u003e\n\u003ctd\u003e¥232.6bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademia\/Trials\u003c\/td\u003e\n\u003ctd\u003eJoint studies\/assay gain\u003c\/td\u003e\n\u003ctd\u003e120+, +22% sensitivity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSuppliers\u003c\/td\u003e\n\u003ctd\u003eContract share\/defect rate\u003c\/td\u003e\n\u003ctd\u003e60–70%, \u0026lt;0.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIT partners\u003c\/td\u003e\n\u003ctd\u003eDigital revenue\/growth\u003c\/td\u003e\n\u003ctd\u003e¥48bn, +12% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic programs\u003c\/td\u003e\n\u003ctd\u003eInstitutional revenue\u003c\/td\u003e\n\u003ctd\u003e¥28.4bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for Sysmex mapping customer segments, channels, value propositions, revenue streams, key resources, partners, activities, cost structure, and customer relationships—grounded in the company’s diagnostics and life-science operations and ready for presentations, investor review, and strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Sysmex’s business model with editable cells to quickly map diagnostics, recurring reagent revenues, and channel partnerships—great for brainstorming, boardrooms, or teaching and saves hours of structuring while remaining shareable for team collaboration.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSysmex invests roughly 8–10% of annual revenue into R\u0026amp;D (about JPY 40–50 billion in FY2024), funding interdisciplinary teams in biotech, electronics, and software to advance hematology and hemostasis instruments and AI-driven diagnostics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSysmex runs advanced facilities producing high-precision hematology and coagulation analyzers plus reagents, with FY2024 capital expenditure of ¥27.8 billion (about $188M) to upgrade automation lines; these plants follow ISO 13485 and lean manufacturing to keep defect rates under 50 ppm. Efficient production cut per-unit direct costs by ~8% in 2023, enabling supply for 190+ countries while lowering CO2 emissions per unit by 12% vs 2020.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Marketing and Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSysmex runs global marketing and sales that reach 190+ countries, supporting a 7,400-strong workforce and a direct sales force delivering technical support for complex labs; in FY2024 Sysmex reported ¥337.2 billion revenue, with diagnostic instruments and reagents driving ~78% of sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical Support and Maintenance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eProviding comprehensive after-sales support is a core activity that ensures reliability and longevity of Sysmex diagnostic systems, with preventative maintenance, emergency repairs, and troubleshooting delivered by a global field-engineer network supporting 190+ countries.\u003c\/p\u003e\n\u003cp\u003eHigh-quality service reduces lab downtime—Sysmex reported service-related revenue of ¥120 billion in FY2024 and claims SLA-driven uptime improvements often exceeding 98%, keeping customer satisfaction and retention high.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePreventative maintenance: scheduled visits, software updates\u003c\/li\u003e\n\u003cli\u003eEmergency repairs: 24\/7 field response in major markets\u003c\/li\u003e\n\u003cli\u003eTechnical troubleshooting: remote and on-site support\u003c\/li\u003e\n\u003cli\u003eGlobal reach: service in 190+ countries\u003c\/li\u003e\n\u003cli\u003eFinancial impact: ¥120B service revenue FY2024; \u0026gt;98% uptime\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Affairs and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSysmex must continuously navigate complex global regulations—FDA (US) and EMA (EU) reviews and MDR\/IVDR in Europe—running clinical evaluations and compiling technical files; in 2024 Sysmex reported R\u0026amp;D and regulatory spend of ~JPY 70.2bn (≈USD 480m), reflecting this effort.\u003c\/p\u003e\n\u003cp\u003eQuality assurance is embedded across R\u0026amp;D, manufacturing, and post-market surveillance; Sysmex logged a device complaint rate under 0.4% in 2024 and invests in CAPA and ISO 13485 compliance to protect patients and reduce recall risk.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory filings: FDA\/EMA\/MDR\/IVDR\u003c\/li\u003e\n\u003cli\u003e2024 regulatory\/R\u0026amp;D spend: JPY 70.2bn (~USD 480m)\u003c\/li\u003e\n\u003cli\u003eDevice complaint rate 2024: \u0026lt;0.4%\u003c\/li\u003e\n\u003cli\u003eStandards: ISO 13485, post-market surveillance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSysmex: ¥337bn revenue, ¥40–50bn R\u0026amp;D (8–10%) and \u0026lt;0.4% device complaints\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSysmex invests 8–10% revenue in R\u0026amp;D (~JPY 40–50bn FY2024), runs ISO 13485 plants (CapEx ¥27.8bn FY2024) serving 190+ countries, and earned ¥337.2bn revenue with ¥120bn service income; regulatory\/R\u0026amp;D spend was JPY 70.2bn and device complaint rate \u0026lt;0.4% in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e¥337.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e¥40–50bn (8–10%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory\/R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e¥70.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapEx\u003c\/td\u003e\n\u003ctd\u003e¥27.8bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService revenue\u003c\/td\u003e\n\u003ctd\u003e¥120bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComplaint rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the exact Sysmex Business Model Canvas you'll receive after purchase—this is not a mockup or sample but a direct snapshot of the final file.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you’ll get full access to the complete, ready-to-use document formatted exactly as shown, suitable for editing, presenting, and sharing.\u003c\/p\u003e\n\u003cp\u003eNo placeholders or marketing examples—what you see is the live deliverable, instantly downloadable in its entirety upon purchase.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748874760569,"sku":"sysmex-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/sysmex-business-model-canvas.png?v=1772211717","url":"https:\/\/matrixbcg.com\/products\/sysmex-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}